Article

Daily Medication Pearl: Besifloxacin (Besivance)

Besifloxacin ophthalmic suspension (Besivance) is indicated for the treatment of bacterial conjunctivitis.

Medication Pearl of the Day: Besivance (besifloxacin)

Indication: Besifloxacin ophthalmic suspension (Besivance) 0.6% is a quinolone antimicrobial indicated for the treatment of bacterial conjunctivitis.

Insight:

  • Dosing: Instill 1 drop in the affected eye(s) 3 times a day, 4 to 12 hours apart for 7 days.
  • Dosage forms:Ophthalmic suspension besifloxacin 6 mg/mL.
  • Adverse events: The most common adverse reaction reported in 2% of patients treated with Besivance was conjunctival redness.
  • Mechanism of action: Besifloxacin is a fluoroquinolone antibacterial agent.
  • Manufacturer: Bausch & Lomb Incorporated.

Sources:

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Image credit: Sebastian Kaulitzki | stock.adobe.com
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com